Showing results (81-90 of 117) with videos related to
Sort By:
Pageof 12
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|October 13, 2022
A Murine Model of Veno-Arterial Extracorporeal Membrane OxygenationMousa Kharnaf, Spencer Hogue, Zachariah Wilkes, et al.British Journal of Haematology|June 8, 2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patientsEldad J Dann, Osnat Bairey, Rachel Bar-Shalom, et al.Journal of Thrombosis and Haemostasis : JTH|August 9, 2024
Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesityHolly Cline, Zimu Wei, Dafna J Groeneveld, et al.Proceedings of the National Academy of Sciences of the United States of America|January 14, 2021
Host fibrinogen drives antimicrobial function in Staphylococcus aureus peritonitis through bacterial-mediated prothrombin activationJoni M Prasad, Oscar Negrón, Xinli Du, et al.Scientific Reports|July 13, 2021
Cell type-specific roles of PAR1 in Coxsackievirus B3 infectionMichael F Bode, Clare M Schmedes, Grant J Egnatz, et al.Hemasphere|December 13, 2021
A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory LymphomaGraham P Collins, Toby A Eyre, Debora Schmitz-Rohmer, et al.Nature Communications|April 6, 2023
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQSandra Schrenk, Lindsay J Bischoff, Jillian Goines, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromasBrigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.Cancer Research|April 9, 2014
Thrombin drives tumorigenesis in colitis-associated colon cancerBrian Turpin, Whitney Miller, Leah Rosenfeldt, et al.Blood|August 1, 2015
Mice expressing a mutant form of fibrinogen that cannot support fibrin formation exhibit compromised antimicrobial host defenseJoni M Prasad, Oleg V Gorkun, Harini Raghu, et al.Pageof 12